Everolimus in patients who have TSC related seizures

• Research type

  Research Study

• Full title

  A three-arm, randomized, double-blind, placebo-controlled study of the efficacy and safety of two trough-ranges of everolimus as adjunctive therapy in patients with tuberous sclerosis complex (TSC) who have refractory partial-onset seizures

• IRAS ID

  120601

• Contact name

  Finbar O'Callaghan

• Contact email

  Finbar.O'Callaghan@gosh.nhs.uk

• Sponsor organisation

  Novartis Pharma Services AG

• Eudract number

  2011-000860-90

• ISRCTN Number

  n/a

• Clinicaltrials.gov Identifier

  n/a

• REC name

  South Central - Berkshire Research Ethics Committee

• REC reference

  13/SC/0183

• Date of REC Opinion

  30 May 2013

• REC opinion

  Further Information Favourable Opinion